These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 7236487

  • 1. In vitro metabolism of misonidazole.
    Josephy PD, Palcic B, Skarsgard LD.
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
    Varghese AJ, Whitmore GF.
    Cancer Res; 1980 Jul; 40(7):2165-9. PubMed ID: 6155991
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
    Raleigh JA, Franko AJ, Koch CJ, Born JL.
    Br J Cancer; 1985 Feb; 51(2):229-35. PubMed ID: 3966980
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic properties of hydroxylamino- and amino-misonidazole, possible metabolic products of misonidazole, in hypoxic HeLa S3 cells.
    Murayama C, Hori H, Mori T, Inayama S.
    Gan; 1983 Oct; 74(5):693-8. PubMed ID: 6642142
    [Abstract] [Full Text] [Related]

  • 9. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
    Franko AJ, Chapman JD.
    Br J Cancer; 1982 May; 45(5):694-9. PubMed ID: 7082555
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Binding of nitroreduction products of misonidazole to nucleic acids and protein.
    Varghese AJ, Whitmore GF.
    Cancer Clin Trials; 1980 May; 3(1):43-6. PubMed ID: 7389036
    [Abstract] [Full Text] [Related]

  • 14. Metabolism and excretion of [3H]misonidazole by hypoxic rat liver.
    Smith BR, Born JL.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1365-70. PubMed ID: 6469758
    [Abstract] [Full Text] [Related]

  • 15. Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites.
    Franko AJ, Koch CJ.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1333-6. PubMed ID: 6469756
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative misonidazole metabolism in anaerobic bacteria and hypoxic Chinese hamster lung fibroblast (V-79-473) cells.
    Koch RL, Rose C, Rich TA, Goldman P.
    Biochem Pharmacol; 1982 Feb 01; 31(3):411-4. PubMed ID: 7073768
    [Abstract] [Full Text] [Related]

  • 19. Changes in misonidazole binding with hypoxic fraction in mouse tumors.
    Hirst DG, Hazlehurst JL, Brown JM.
    Int J Radiat Oncol Biol Phys; 1985 Jul 01; 11(7):1349-55. PubMed ID: 4008291
    [Abstract] [Full Text] [Related]

  • 20. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.
    Garrecht BM, Chapman JD.
    Br J Radiol; 1983 Oct 01; 56(670):745-53. PubMed ID: 6616139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.